Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Bonadona

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bulletin Du Cancer|August 10, 2001
[Medical management of women with inherited predisposition to breast cancer: indications and procedures for mammographic screening]C Lassetn, V Bonadona
Clinical Genetics|August 1, 2014
Germline BAP1 mutations predispose also to multiple basal cell carcinomasA de la Fouchardière, O Cabaret, L Savin, et al.
British Journal of Cancer|January 1, 1997
Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinomaC Bain, Y Merrouche, I Puisieux, et al.
Familial Cancer|September 5, 2009
Molecular study of CEBPA in familial hematological malignanciesR El Abed, V Bourdon, L Huiart, et al.
Bulletin Du Cancer|September 16, 2009
[Cancer genetics: estimation of the needs of the population in France for the next ten years]C Bonaïti-Pellié, N Andrieu, P Arveux, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 20, 2015
Familial hematological malignancies: ASXL1 gene investigationW S Hamadou, R E Abed, S Besbes, et al.
International Journal of Cancer|May 14, 1998
Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC)H Mignotte, C Lasset, V Bonadona, et al.
Journal of Medical Genetics|September 5, 2006
The contribution of germline rearrangements to the spectrum of BRCA2 mutationsF Casilli, I Tournier, O M Sinilnikova, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|August 10, 2001
[Medical management of women with inherited predisposition to breast cancer: indications and procedures for mammographic screening]C Lassetn, V Bonadona
Clinical Genetics|August 1, 2014
Germline BAP1 mutations predispose also to multiple basal cell carcinomasA de la Fouchardière, O Cabaret, L Savin, et al.
British Journal of Cancer|January 1, 1997
Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinomaC Bain, Y Merrouche, I Puisieux, et al.
Familial Cancer|September 5, 2009
Molecular study of CEBPA in familial hematological malignanciesR El Abed, V Bourdon, L Huiart, et al.
Bulletin Du Cancer|September 16, 2009
[Cancer genetics: estimation of the needs of the population in France for the next ten years]C Bonaïti-Pellié, N Andrieu, P Arveux, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 20, 2015
Familial hematological malignancies: ASXL1 gene investigationW S Hamadou, R E Abed, S Besbes, et al.
International Journal of Cancer|May 14, 1998
Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC)H Mignotte, C Lasset, V Bonadona, et al.
Journal of Medical Genetics|September 5, 2006
The contribution of germline rearrangements to the spectrum of BRCA2 mutationsF Casilli, I Tournier, O M Sinilnikova, et al.
Pageof 1